APO RESEARCH · REPORT
Oncology Based Preclinical CRO
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
Product & engineering
Understand the product.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
Selected research
Industry Growth & Trends
Global Oncology Based Preclinical CRO Industry Growth and Trends Forecast to 2032
Market perspective
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
According to APO Research, the global Oncology Based Preclinical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Oncology Based Preclinical CRO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oncology Based Preclinical CRO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology Based Preclinical CRO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology Based Preclinical CRO.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Oncology Based Preclinical CRO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oncology Based Preclinical CRO Market by Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Oncology Based Preclinical CRO Segment by Type
Blood Cancer
Solid Tumors
Others
Oncology Based Preclinical CRO Segment by Application
In Vitro
In Vivo
Oncology Based Preclinical CRO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Based Preclinical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology Based Preclinical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Based Preclinical CRO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Oncology Based Preclinical CRO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Cancer
- Solid Tumors
- Others
Applications
- In Vitro
- In Vivo
Companies covered
- Crown Bioscience
- Charles River
- ICON
- Eurofins Scientific
- Taconic Biosciences
- Covance
- EVOTEC
- The Jackson Laboratory
- MI Bioresearch
- Champion Oncology
- Wuxi AppTec.
- Xentech
- Living Tumor Laboratory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Oncology Based Preclinical CRO Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Oncology Based Preclinical CRO Market Size by Region (2021-2032)
- 1.4.1 Global Oncology Based Preclinical CRO Market Size by Region (2021-2026)
- 1.4.2 Global Oncology Based Preclinical CRO Market Size by Region (2027-2032)
- 1.5 Key Regions Oncology Based Preclinical CRO Market Size (2021-2032)
- 1.5.1 North America Oncology Based Preclinical CRO Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Oncology Based Preclinical CRO Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Oncology Based Preclinical CRO Market Size Growth Rate (2021-2032)
- 1.5.4 South America Oncology Based Preclinical CRO Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Oncology Based Preclinical CRO Market Size Growth Rate (2021-2032)
2 Oncology Based Preclinical CRO Market by Type
- 2.1 Type Introduction
- 2.1.1 Blood Cancer
- 2.1.2 Solid Tumors
- 2.1.3 Others
- 2.2 Global Oncology Based Preclinical CRO Market Size by Type
- 2.2.1 Global Oncology Based Preclinical CRO Market Size Overview by Type (2021-2032)
- 2.2.2 Global Oncology Based Preclinical CRO Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Oncology Based Preclinical CRO Market Size Forecasted by Type (2027-2032)
- 2.3 Global Oncology Based Preclinical CRO Market Size by Regions
- 2.3.1 North America Oncology Based Preclinical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Oncology Based Preclinical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Oncology Based Preclinical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Oncology Based Preclinical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Oncology Based Preclinical CRO Market Size Breakdown by Type (2021-2026)
3 Oncology Based Preclinical CRO Market by Application
- 3.1 Type Introduction
- 3.1.1 In Vitro
- 3.1.2 In Vivo
- 3.2 Global Oncology Based Preclinical CRO Market Size by Application
- 3.2.1 Global Oncology Based Preclinical CRO Market Size Overview by Application (2021-2032)
- 3.2.2 Global Oncology Based Preclinical CRO Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Oncology Based Preclinical CRO Market Size Forecasted by Application (2027-2032)
- 3.3 Global Oncology Based Preclinical CRO Market Size by Regions
- 3.3.1 North America Oncology Based Preclinical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Oncology Based Preclinical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Oncology Based Preclinical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Oncology Based Preclinical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Oncology Based Preclinical CRO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Oncology Based Preclinical CRO Industry Trends
- 4.2 Oncology Based Preclinical CRO Industry Drivers
- 4.3 Oncology Based Preclinical CRO Industry Opportunities and Challenges
- 4.4 Oncology Based Preclinical CRO Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Oncology Based Preclinical CRO Revenue (2021-2026)
- 5.2 Global Oncology Based Preclinical CRO Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Oncology Based Preclinical CRO Key Company Headquarters & Area Served
- 5.4 Global Oncology Based Preclinical CRO Company, Product Type & Application
- 5.5 Global Oncology Based Preclinical CRO Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Oncology Based Preclinical CRO Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Oncology Based Preclinical CRO Players Market Share by Revenue in 2025
- 5.6.3 2025 Oncology Based Preclinical CRO Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Crown Bioscience
- 6.1.1 Crown Bioscience Company Information
- 6.1.2 Crown Bioscience Business Overview
- 6.1.3 Crown Bioscience Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Crown Bioscience Oncology Based Preclinical CRO Product Portfolio
- 6.1.5 Crown Bioscience Recent Developments
- 6.2 Charles River
- 6.2.1 Charles River Company Information
- 6.2.2 Charles River Business Overview
- 6.2.3 Charles River Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Charles River Oncology Based Preclinical CRO Product Portfolio
- 6.2.5 Charles River Recent Developments
- 6.3 ICON
- 6.3.1 ICON Company Information
- 6.3.2 ICON Business Overview
- 6.3.3 ICON Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ICON Oncology Based Preclinical CRO Product Portfolio
- 6.3.5 ICON Recent Developments
- 6.4 Eurofins Scientific
- 6.4.1 Eurofins Scientific Company Information
- 6.4.2 Eurofins Scientific Business Overview
- 6.4.3 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Eurofins Scientific Oncology Based Preclinical CRO Product Portfolio
- 6.4.5 Eurofins Scientific Recent Developments
- 6.5 Taconic Biosciences
- 6.5.1 Taconic Biosciences Company Information
- 6.5.2 Taconic Biosciences Business Overview
- 6.5.3 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Taconic Biosciences Oncology Based Preclinical CRO Product Portfolio
- 6.5.5 Taconic Biosciences Recent Developments
- 6.6 Covance
- 6.6.1 Covance Company Information
- 6.6.2 Covance Business Overview
- 6.6.3 Covance Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Covance Oncology Based Preclinical CRO Product Portfolio
- 6.6.5 Covance Recent Developments
- 6.7 EVOTEC
- 6.7.1 EVOTEC Company Information
- 6.7.2 EVOTEC Business Overview
- 6.7.3 EVOTEC Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 EVOTEC Oncology Based Preclinical CRO Product Portfolio
- 6.7.5 EVOTEC Recent Developments
- 6.8 The Jackson Laboratory
- 6.8.1 The Jackson Laboratory Company Information
- 6.8.2 The Jackson Laboratory Business Overview
- 6.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 The Jackson Laboratory Oncology Based Preclinical CRO Product Portfolio
- 6.8.5 The Jackson Laboratory Recent Developments
- 6.9 MI Bioresearch
- 6.9.1 MI Bioresearch Company Information
- 6.9.2 MI Bioresearch Business Overview
- 6.9.3 MI Bioresearch Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MI Bioresearch Oncology Based Preclinical CRO Product Portfolio
- 6.9.5 MI Bioresearch Recent Developments
- 6.10 Champion Oncology
- 6.10.1 Champion Oncology Company Information
- 6.10.2 Champion Oncology Business Overview
- 6.10.3 Champion Oncology Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Champion Oncology Oncology Based Preclinical CRO Product Portfolio
- 6.10.5 Champion Oncology Recent Developments
- 6.11 Wuxi AppTec.
- 6.11.1 Wuxi AppTec. Company Information
- 6.11.2 Wuxi AppTec. Business Overview
- 6.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Wuxi AppTec. Oncology Based Preclinical CRO Product Portfolio
- 6.11.5 Wuxi AppTec. Recent Developments
- 6.12 Xentech
- 6.12.1 Xentech Company Information
- 6.12.2 Xentech Business Overview
- 6.12.3 Xentech Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Xentech Oncology Based Preclinical CRO Product Portfolio
- 6.12.5 Xentech Recent Developments
- 6.13 Living Tumor Laboratory
- 6.13.1 Living Tumor Laboratory Company Information
- 6.13.2 Living Tumor Laboratory Business Overview
- 6.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Living Tumor Laboratory Oncology Based Preclinical CRO Product Portfolio
- 6.13.5 Living Tumor Laboratory Recent Developments
7 North America
- 7.1 North America Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 7.3 North America Oncology Based Preclinical CRO Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 8.3 Europe Oncology Based Preclinical CRO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Oncology Based Preclinical CRO Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 10.3 South America Oncology Based Preclinical CRO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Oncology Based Preclinical CRO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst